NovaBay Pharmaceuticals Inc (NBY) — Dilution Risk Analysis

Current Snapshot

NovaBay Pharmaceuticals Inc (NBY) has a DilutionWatch score of 70/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
50,615,437 Source
Public Float
2,624,429 Source
Float as % of Outstanding
5.2%

Dilution Risk Score

Score: 70/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: XBRL 1, 4 5, 8-K 3, 424B5 1.

FormFiledAccession
xbrl 2026-06-30 xbrl-6086-xbrl_warrant
4 2026-04-09 0001437749-26-011913
4 2026-04-08 0001437749-26-011781
4 2026-04-02 0001437749-26-011164
4 2026-04-02 0001437749-26-011195
8-K 2026-04-01 0001437749-26-010902
8-K 2026-03-12 0001437749-26-008015
4 2026-01-29 0000921895-26-000165
424B5 2026-01-20 0001437749-26-001489
8-K 2026-01-20 0001437749-26-001490

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $100,000,000 Source
Cash runway 13 months Source
Three-year share count growth 9999.0% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 70/10) Source
Cash Runway
13 months Source
ATM Offering Capacity Remaining
$100,000,000 Source
Share Count Growth (3-Year)
9999.0% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.